AVALIDE - IRBESARTAN AND HYDROCHLOROTHIAZIDE
Navigation: NDC > Supplier starting with: B > BRISTOL MYERS SQUIBB COMPANY| Field | Value |
|---|---|
| NDC Code: | 0087-2775 |
| Proprietary Name: | AVALIDE |
| Suffix: | |
| Non-Proprietary Name: | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 30-09-1997 |
| End of Marketing: | 30-11-2014 |
| Category Name: | NDA |
| Application Number: | NDA020758 |
| Labeler: | BRISTOL MYERS SQUIBB COMPANY |
| Substance Name: | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Active Numerator Strength: | 12.5; 150 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |